{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:16:55Z","timestamp":1793776615847,"version":"4.6.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol Exp"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Despite widespread study of dendritic cell (DC)-based cancer immunotherapies, the\n                      <jats:italic>in vivo<\/jats:italic>\n                      postinjection fate of DC remains largely unknown. Due in part to a lack of quantifiable imaging modalities, this is troubling as the amount of DC migration to secondary lymphoid organs correlates with therapeutic efficacy. Magnetic particle imaging (MPI) has emerged as a suitable modality to quantify\n                      <jats:italic>in vivo<\/jats:italic>\n                      migration of superparamagnetic iron oxide (SPIO)-labeled DC. Herein, we describe a popliteal lymph node (pLN)-focused MPI scan to quantify DC\n                      <jats:italic>in vivo<\/jats:italic>\n                      migration accurately and consistently.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Adenovirus (Ad)-transduced SPIO\n                      <jats:sup>+<\/jats:sup>\n                      (Ad SPIO\n                      <jats:sup>+<\/jats:sup>\n                      ) and SPIO\n                      <jats:sup>+<\/jats:sup>\n                      C57BL\/6 bone marrow-derived DC were generated and assessed for viability and phenotype, then fluorescently labeled and injected into mouse hind footpads (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096). Two days later,\n                      <jats:italic>in vivo<\/jats:italic>\n                      DC migration was quantified using whole animal, pLN-focused, and\n                      <jats:italic>ex vivo<\/jats:italic>\n                      pLN MPI scans.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      No significant differences in viability, phenotype and\n                      <jats:italic>in vivo<\/jats:italic>\n                      pLN migration were noted for Ad SPIO\n                      <jats:sup>+<\/jats:sup>\n                      and SPIO\n                      <jats:sup>+<\/jats:sup>\n                      DC. Day 2 pLN-focused MPI quantified DC migration in all instances while whole animal MPI only quantified pLN migration in 75% of cases.\n                      <jats:italic>Ex vivo<\/jats:italic>\n                      MPI and fluorescence microscopy confirmed that pLN MPI signal was due to originally injected Ad SPIO\n                      <jats:sup>+<\/jats:sup>\n                      and SPIO\n                      <jats:sup>+<\/jats:sup>\n                      DC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      We overcame a reported limitation of MPI by using a pLN-focused MPI scan to quantify pLN-migrated Ad SPIO\n                      <jats:sup>+<\/jats:sup>\n                      and SPIO\n                      <jats:sup>+<\/jats:sup>\n                      DC in 100% of cases and detected as few as 1000 DC (4.4\u00a0ng Fe)\n                      <jats:italic>in vivo<\/jats:italic>\n                      . MPI is a suitable preclinical imaging modality to assess DC-based cancer immunotherapeutic efficacy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Relevance statement<\/jats:title>\n                    <jats:p>\n                      Tracking the\n                      <jats:italic>in vivo<\/jats:italic>\n                      fate of DC using noninvasive quantifiable magnetic particle imaging can potentially serve as a surrogate marker of therapeutic effectiveness.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key points<\/jats:title>\n                    <jats:p>\n                      \u2022 Adenoviral-transduced and iron oxide-labeled dendritic cells are\n                      <jats:italic>in vivo<\/jats:italic>\n                      migration\u00a0competent.\n                    <\/jats:p>\n                    <jats:p>\n                      \u2022 Magnetic particle imaging is a suitable modality to quantify\n                      <jats:italic>in vivo<\/jats:italic>\n                      dendritic cell migration.\n                    <\/jats:p>\n                    <jats:p>\u2022 Magnetic particle imaging focused field of view overcomes dynamic range limitation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s41747-023-00359-4","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T20:01:51Z","timestamp":1692043311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["In vivo tracking of adenoviral-transduced iron oxide-labeled bone marrow-derived dendritic cells using magnetic particle imaging"],"prefix":"10.1186","volume":"7","author":[{"given":"Corby","family":"Fink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia J.","family":"Gevaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy D.","family":"Dikeakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula J.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3087-4660","authenticated-orcid":false,"given":"Gregory A.","family":"Dekaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,15]]},"reference":[{"key":"359_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1021\/ACSABM.2C00790","volume":"6","author":"Y Gao","year":"2022","unstructured":"Gao Y, Wang Z, Cui Y, Xu M, Weng L (2022) Emerging strategies of engineering and tracking dendritic cells for cancer immunotherapy. ACS Appl Bio Mater 6:24\u201343. https:\/\/doi.org\/10.1021\/ACSABM.2C00790","journal-title":"ACS Appl Bio Mater"},{"key":"359_CR2","first-page":"491","volume":"87","author":"J Datta","year":"2014","unstructured":"Datta J, Terhune JH, Lowenfeld L et al (2014) Optimizing dendritic cell-based approaches for cancer immunotherapy. Yale J Biol Med 87:491\u2013518","journal-title":"Yale J Biol Med"},{"key":"359_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/J.GENDIS.2017.04.001","volume":"4","author":"CS Lee","year":"2017","unstructured":"Lee CS, Bishop ES, Zhang R et al (2017) Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine. Genes Dis 4:43\u201363. https:\/\/doi.org\/10.1016\/J.GENDIS.2017.04.001","journal-title":"Genes Dis"},{"key":"359_CR4","doi-asserted-by":"publisher","first-page":"a028472","DOI":"10.1101\/CSHPERSPECT.A028472","volume":"10","author":"TA Waldmann","year":"2018","unstructured":"Waldmann TA (2018) Cytokines in cancer immunotherapy. Cold Spring Harb Perspect Biol 10:a028472. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A028472","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"359_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1470-2045(13)70585-0","volume":"15","author":"S Anguille","year":"2014","unstructured":"Anguille S, Smits EL, Lion E, Van Tendeloo VF, Berneman ZN (2014) Clinical use of dendritic cells for cancer therapy. Lancet Oncol 15:257\u2013267. https:\/\/doi.org\/10.1016\/S1470-2045(13)70585-0","journal-title":"Lancet Oncol"},{"key":"359_CR6","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3389\/FIMMU.2013.00454","volume":"4","author":"LH Butterfield","year":"2013","unstructured":"Butterfield LH (2013) Dendritic cells in cancer immunotherapy clinical trials: are we making progress? Front Immunol 4:454. https:\/\/doi.org\/10.3389\/FIMMU.2013.00454","journal-title":"Front Immunol"},{"key":"359_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/J.IT.2012.02.007","volume":"33","author":"R F\u00f6rster","year":"2012","unstructured":"F\u00f6rster R, Braun A, Worbs T (2012) Lymph node homing of T cells and dendritic cells via afferent lymphatics. Trends Immunol 33:271\u2013280. https:\/\/doi.org\/10.1016\/J.IT.2012.02.007","journal-title":"Trends Immunol"},{"key":"359_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1084\/JEM.20030448","volume":"198","author":"A Mart\u00edn-Fontecha","year":"2003","unstructured":"Mart\u00edn-Fontecha A, Sebastiani S, H\u00f6pken UE et al (2003) Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 198:615\u2013621. https:\/\/doi.org\/10.1084\/JEM.20030448","journal-title":"J Exp Med"},{"key":"359_CR9","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1158\/2326-6066.CIR-15-0189","volume":"4","author":"E Scheid","year":"2016","unstructured":"Scheid E, Major P, Bergeron A et al (2016) Tn-MUC1 DC vaccination of Rhesus macaques and a phase I\/II trial in patients with nonmetastatic castrate-resistant prostate cancer. Cancer Immunol Res 4:881\u2013892. https:\/\/doi.org\/10.1158\/2326-6066.CIR-15-0189","journal-title":"Cancer Immunol Res"},{"key":"359_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4161\/ONCI.18628","volume":"1","author":"LAT Blalock","year":"2012","unstructured":"Blalock LAT, Landsberg J, Messmer MN et al (2012) Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity. Oncoimmunology 1:287\u2013357. https:\/\/doi.org\/10.4161\/ONCI.18628","journal-title":"Oncoimmunology"},{"key":"359_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/WNAN.1227","volume":"5","author":"GA Dekaban","year":"2013","unstructured":"Dekaban GA, Hamilton AM, Fink CA et al (2013) Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 5:469\u2013483. https:\/\/doi.org\/10.1002\/WNAN.1227","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"359_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/INTIMM\/DXR095","volume":"24","author":"S de Chickera","year":"2012","unstructured":"de Chickera S, Willert C, Mallet C, Foley R, Foster P, Dekaban GA (2012) Cellular MRI as a suitable, sensitive non-invasive modality for correlating in vivo migratory efficiencies of different dendritic cell populations with subsequent immunological outcomes. Int Immunol 24:29\u201341. https:\/\/doi.org\/10.1093\/INTIMM\/DXR095","journal-title":"Int Immunol"},{"key":"359_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/CMMI.433","volume":"6","author":"SN de Chickera","year":"2011","unstructured":"de Chickera SN, Snir J, Willert C et al (2011) Labelling dendritic cells with SPIO has implications for their subsequent in vivo migration as assessed with cellular MRI. Contrast Media Mol Imaging 6:314\u2013327. https:\/\/doi.org\/10.1002\/CMMI.433","journal-title":"Contrast Media Mol Imaging"},{"key":"359_CR14","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/S11307-022-01738-W","volume":"24","author":"JJ Gevaert","year":"2022","unstructured":"Gevaert JJ, Fink C, Dikeakos JD, Dekaban GA, Foster PJ (2022) Magnetic particle imaging is a sensitive in vivo imaging modality for the detection of dendritic cell migration. Mol Imaging Biol 24:886\u2013897. https:\/\/doi.org\/10.1007\/S11307-022-01738-W","journal-title":"Mol Imaging Biol"},{"key":"359_CR15","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/NBT1154","volume":"23","author":"IJM de Vries","year":"2005","unstructured":"de Vries IJM, Lesterhuis WJ, Barentsz JO et al (2005) Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 23:1407\u20131413. https:\/\/doi.org\/10.1038\/NBT1154","journal-title":"Nat Biotechnol"},{"key":"359_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/MRM.20747","volume":"55","author":"C Heyn","year":"2006","unstructured":"Heyn C, Ronald JA, Mackenzie LT et al (2006) In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magn Reson Med 55:23\u201329. https:\/\/doi.org\/10.1002\/MRM.20747","journal-title":"Magn Reson Med"},{"key":"359_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/CJI.0B013E318197B2A0","volume":"32","author":"GA Dekaban","year":"2009","unstructured":"Dekaban GA, Snir J, Shrum B et al (2009) Semiquantitation of mouse dendritic cell migration in vivo using cellular MRI. J Immunother 32:240\u2013251. https:\/\/doi.org\/10.1097\/CJI.0B013E318197B2A0","journal-title":"J Immunother"},{"key":"359_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/S11307-021-01647-4","volume":"24","author":"JWM Bulte","year":"2022","unstructured":"Bulte JWM, Shakeri-Zadeh A (2022) In vivo MRI tracking of tumor vaccination and antigen presentation by dendritic cells. Mol Imaging Biol 24:198\u2013207. https:\/\/doi.org\/10.1007\/S11307-021-01647-4","journal-title":"Mol Imaging Biol"},{"key":"359_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.7150\/THNO.13728","volume":"6","author":"B Zheng","year":"2016","unstructured":"Zheng B, Von See MP, Yu E et al (2016) Quantitative magnetic particle imaging monitors the transplantation, biodistribution, and clearance of stem cells in vivo. Theranostics 6:291\u2013301. https:\/\/doi.org\/10.7150\/THNO.13728","journal-title":"Theranostics"},{"key":"359_CR20","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1038\/S41598-020-58853-3","volume":"10","author":"H Paysen","year":"2020","unstructured":"Paysen H, Loewa N, Stach A et al (2020) Cellular uptake of magnetic nanoparticles imaged and quantified by magnetic particle imaging. Sci Rep 10:1922. https:\/\/doi.org\/10.1038\/S41598-020-58853-3","journal-title":"Sci Rep"},{"key":"359_CR21","doi-asserted-by":"publisher","first-page":"6872","DOI":"10.1038\/S41598-017-06992-5","volume":"7","author":"M Graeser","year":"2017","unstructured":"Graeser M, Knopp T, Szwargulski P et al (2017) Towards picogram detection of superparamagnetic iron-oxide particles using a gradiometric receive coil. Sci Rep 7:6872. https:\/\/doi.org\/10.1038\/S41598-017-06992-5","journal-title":"Sci Rep"},{"key":"359_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1166\/JBN.2016.2204","volume":"12","author":"WC Poller","year":"2016","unstructured":"Poller WC, L\u00f6wa N, Wiekhorst F et al (2016) Magnetic particle spectroscopy reveals dynamic changes in the magnetic behavior of very small superparamagnetic iron oxide nanoparticles during cellular uptake and enables determination of cell-labeling efficacy. J Biomed Nanotechnol 12:337\u2013346. https:\/\/doi.org\/10.1166\/JBN.2016.2204","journal-title":"J Biomed Nanotechnol"},{"key":"359_CR23","doi-asserted-by":"publisher","first-page":"R124","DOI":"10.1088\/1361-6560\/AA6C99","volume":"62","author":"T Knopp","year":"2017","unstructured":"Knopp T, Gdaniec N, M\u00f6ddel M (2017) Magnetic particle imaging: from proof of principle to preclinical applications. Phys Med Biol 62:R124\u2013R178. https:\/\/doi.org\/10.1088\/1361-6560\/AA6C99","journal-title":"Phys Med Biol"},{"key":"359_CR24","doi-asserted-by":"publisher","first-page":"348","DOI":"10.7150\/NTNO.58548","volume":"5","author":"S Liu","year":"2021","unstructured":"Liu S, Chiu-Lam A, Rivera-Rodriguez A et al (2021) Long circulating tracer tailored for magnetic particle imaging. Nanotheranostics 5:348\u2013361. https:\/\/doi.org\/10.7150\/NTNO.58548","journal-title":"Nanotheranostics"},{"key":"359_CR25","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1038\/S41467-019-09704-X","volume":"10","author":"M Graeser","year":"2019","unstructured":"Graeser M, Thieben F, Szwargulski P et al (2019) Human-sized magnetic particle imaging for brain applications. Nat Commun 10:1936. https:\/\/doi.org\/10.1038\/S41467-019-09704-X","journal-title":"Nat Commun"},{"key":"359_CR26","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/S11307-019-01393-8","volume":"22","author":"C Fink","year":"2020","unstructured":"Fink C, Smith M, Gaudet JM, Makela A, Foster PJ, Dekaban GA (2020) Fluorine-19 cellular MRI detection of in vivo dendritic cell migration and subsequent induction of tumor antigen-specific immunotherapeutic response. Mol Imaging Biol 22:549\u2013561. https:\/\/doi.org\/10.1007\/S11307-019-01393-8","journal-title":"Mol Imaging Biol"},{"key":"359_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1479-0556-6-5","volume":"6","author":"D Damjanovic","year":"2008","unstructured":"Damjanovic D, Zhang X, Mu J, Fe Medina M, Xing Z (2008) Organ distribution of transgene expression following intranasal mucosal delivery of recombinant replication-defective adenovirus gene transfer vector. Genet Vaccines Ther 6:5. https:\/\/doi.org\/10.1186\/1479-0556-6-5","journal-title":"Genet Vaccines Ther"},{"key":"359_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18416\/IJMPI.2021.2103003","volume":"7","author":"P Vogel","year":"2021","unstructured":"Vogel P, Kampf T, R\u00fcckert MA et al (2021) Synomag\u00ae: The new high-performance tracer for magnetic particle imaging. Int J Magn Part Imaging 7:1\u20136. https:\/\/doi.org\/10.18416\/IJMPI.2021.2103003","journal-title":"Int J Magn Part Imaging"},{"key":"359_CR29","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/S41598-017-19031-0","volume":"8","author":"C Fink","year":"2018","unstructured":"Fink C, Gaudet JM, Fox MS et al (2018) 19F-perfluorocarbon-labeled human peripheral blood mononuclear cells can be detected in vivo using clinical MRI parameters in a therapeutic cell setting. Sci Rep 8:590. https:\/\/doi.org\/10.1038\/S41598-017-19031-0","journal-title":"Sci Rep"},{"key":"359_CR30","doi-asserted-by":"publisher","first-page":"e0140137","DOI":"10.1371\/JOURNAL.PONE.0140137","volume":"10","author":"JJ Konkle","year":"2015","unstructured":"Konkle JJ, Goodwill PW, Hensley DW, Orendorff RD, Lustig M, Conolly SM (2015) A convex formulation for magnetic particle imaging x-space reconstruction. PLoS One 10:e0140137. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0140137","journal-title":"PLoS One"},{"key":"359_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4049\/JIMMUNOL.1701024","volume":"200","author":"PM Santos","year":"2018","unstructured":"Santos PM, Butterfield LH (2018) Dendritic cell-based cancer vaccines. J Immunol 200:71\u201374. https:\/\/doi.org\/10.4049\/JIMMUNOL.1701024","journal-title":"J Immunol"},{"key":"359_CR32","doi-asserted-by":"publisher","first-page":"12339","DOI":"10.3390\/IJMS222212339","volume":"22","author":"S Nava","year":"2021","unstructured":"Nava S, Lisini D, Frigerio S, Bersano A (2021) Dendritic cells and cancer immunotherapy: the adjuvant effect. Int J Mol Sci 22:12339. https:\/\/doi.org\/10.3390\/IJMS222212339","journal-title":"Int J Mol Sci"},{"key":"359_CR33","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/MRM.22313","volume":"63","author":"S Kobukai","year":"2010","unstructured":"Kobukai S, Baheza R, Cobb JG et al (2010) Magnetic nanoparticles for imaging dendritic cells. Magn Reson Med 63:1383\u20131390. https:\/\/doi.org\/10.1002\/MRM.22313","journal-title":"Magn Reson Med"},{"key":"359_CR34","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.7150\/THNO.39554","volume":"10","author":"H Nejadnik","year":"2020","unstructured":"Nejadnik H, Jung KO, Theruvath AJ et al (2020) Instant labeling of therapeutic cells for multimodality imaging. Theranostics 10:6024\u20136034. https:\/\/doi.org\/10.7150\/THNO.39554","journal-title":"Theranostics"},{"key":"359_CR35","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/J.ADDR.2019.01.005","volume":"138","author":"SM Dadfar","year":"2019","unstructured":"Dadfar SM, Roemhild K, Drude NI et al (2019) Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications. Adv Drug Deliv Rev 138:302\u2013325. https:\/\/doi.org\/10.1016\/J.ADDR.2019.01.005","journal-title":"Adv Drug Deliv Rev"},{"key":"359_CR36","doi-asserted-by":"publisher","first-page":"898426","DOI":"10.3389\/FPHYS.2022.898426","volume":"13","author":"X Yang","year":"2022","unstructured":"Yang X, Shao G, Zhang Y et al (2022) Applications of magnetic particle imaging in biomedicine: advancements and prospects. Front Physiol 13:898426. https:\/\/doi.org\/10.3389\/FPHYS.2022.898426","journal-title":"Front Physiol"},{"key":"359_CR37","doi-asserted-by":"publisher","unstructured":"Mendell JR, Al-Zaidy SA, Rodino-Klapac LR et al (2021) Current clinical applications of in vivo gene therapy with AAVs. Mol Ther 29:464\u2013488. https:\/\/doi.org\/10.1016\/J.YMTHE.2020.12.007","DOI":"10.1016\/J.YMTHE.2020.12.007"},{"key":"359_CR38","doi-asserted-by":"publisher","first-page":"e1356964","DOI":"10.1080\/2162402X.2017.1356964","volume":"6","author":"B Montico","year":"2017","unstructured":"Montico B, Lapenta C, Ravo M et al (2017) Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy. Oncoimmunology 6:e1356964. https:\/\/doi.org\/10.1080\/2162402X.2017.1356964","journal-title":"Oncoimmunology"},{"key":"359_CR39","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/CJI.0B013E3181ECCBD4","volume":"33","author":"BN Hangalapura","year":"2010","unstructured":"Hangalapura BN, Oosterhoff D, Aggarwal S et al (2010) Selective transduction of dendritic cells in human lymph nodes and superior induction of high-avidity melanoma-reactive cytotoxic T cells by a CD40-targeted adenovirus. J Immunother 33:706\u2013715. https:\/\/doi.org\/10.1097\/CJI.0B013E3181ECCBD4","journal-title":"J Immunother"},{"key":"359_CR40","doi-asserted-by":"publisher","first-page":"106034","DOI":"10.1016\/J.PHRS.2021.106034","volume":"175","author":"J Ding","year":"2022","unstructured":"Ding J, Jiang N, Zheng Y et al (2022) Adenovirus vaccindoi: e therapy with CD137L promotes CD8+ DCs-mediated multifunctional CD8+ T cell immunity and elicits potent anti-tumor activity. Pharmacol Res 175:106034. https:\/\/doi.org\/10.1016\/J.PHRS.2021.106034","journal-title":"Pharmacol Res"},{"key":"359_CR41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/J.OMTO.2022.01.003","volume":"24","author":"J Wenthe","year":"2022","unstructured":"Wenthe J, Naseri S, Hellstr\u00f6m AC et al (2022) Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibition. Mol Ther Oncolytics 24:429\u2013442. https:\/\/doi.org\/10.1016\/J.OMTO.2022.01.003","journal-title":"Mol Ther Oncolytics"},{"key":"359_CR42","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/J.OMTO.2021.02.006","volume":"20","author":"E Yl\u00f6sm\u00e4ki","year":"2021","unstructured":"Yl\u00f6sm\u00e4ki E, Yl\u00f6sm\u00e4ki L, Fusciello M et al (2021) Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform. Mol Ther Oncolytics 20:459\u2013469. https:\/\/doi.org\/10.1016\/J.OMTO.2021.02.006","journal-title":"Mol Ther Oncolytics"},{"key":"359_CR43","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.3892\/OR.2015.4231","volume":"34","author":"QF Sun","year":"2015","unstructured":"Sun QF, Zhao XN, Peng CL et al (2015) Immunotherapy for Lewis lung carcinoma utilizing dendritic cells infected with CK19 gene recombinant adenoviral vectors. Oncol Rep 34:2289\u20132295. https:\/\/doi.org\/10.3892\/OR.2015.4231","journal-title":"Oncol Rep"},{"key":"359_CR44","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/J.YMTHE.2004.07.013","volume":"10","author":"N Tatsis","year":"2004","unstructured":"Tatsis N, Ertl HCJ (2004) Adenoviruses as vaccine vectors. Mol Ther 10:616\u2013629. https:\/\/doi.org\/10.1016\/J.YMTHE.2004.07.013","journal-title":"Mol Ther"},{"key":"359_CR45","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1128\/JVI.76.6.2899-2911.2002","volume":"76","author":"S Mercier","year":"2002","unstructured":"Mercier S, Gah\u00e9ry-Segard H, Monteil M et al (2002) Distinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product. J Virol 76:2899\u20132911. https:\/\/doi.org\/10.1128\/JVI.76.6.2899-2911.2002","journal-title":"J Virol"},{"key":"359_CR46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/V14010092","volume":"14","author":"A Strack","year":"2022","unstructured":"Strack A, Deinzer A, Thirion C et al (2022) Breaking entry-and species barriers: LentiBOOST\u00ae plus polybrene enhances transduction efficacy of dendritic cells and monocytes by Adenovirus 5. Viruses 14:92. https:\/\/doi.org\/10.3390\/V14010092","journal-title":"Viruses"},{"key":"359_CR47","doi-asserted-by":"publisher","first-page":"0239","DOI":"10.1371\/JOURNAL.PPAT.0030025","volume":"3","author":"C Cheng","year":"2007","unstructured":"Cheng C, Gall JGD, Kong WP et al (2007) Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells. PLoS Pathog 3:0239\u20130245. https:\/\/doi.org\/10.1371\/JOURNAL.PPAT.0030025","journal-title":"PLoS Pathog"},{"key":"359_CR48","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/FIMMU.2014.00165","volume":"5","author":"F Wimmers","year":"2014","unstructured":"Wimmers F, Schreibelt G, Sk\u00f6ld AE, Figdor CG, De Vries IJM (2014) Paradigm shift in dendritic cell-based immunotherapy: from in vitro generated monocyte-derived DCs to naturally circulating DC subsets. Front Immunol 5:165. https:\/\/doi.org\/10.3389\/FIMMU.2014.00165","journal-title":"Front Immunol"},{"key":"359_CR49","doi-asserted-by":"publisher","first-page":"635221","DOI":"10.3389\/FCELL.2021.635221","volume":"9","author":"M Feng","year":"2021","unstructured":"Feng M, Zhou S, Yu Y, Su Q, Li X, Lin W (2021) Regulation of the migration of distinct dendritic cell subsets. Front Cell Dev Biol 9:635221. https:\/\/doi.org\/10.3389\/FCELL.2021.635221","journal-title":"Front Cell Dev Biol"},{"key":"359_CR50","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1002\/EJI.1830271209","volume":"27","author":"H Jonuleit","year":"1997","unstructured":"Jonuleit H, K\u00fchn U, M\u00fcller G et al (1997) Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 27:3135\u20133142. https:\/\/doi.org\/10.1002\/EJI.1830271209","journal-title":"Eur J Immunol"},{"key":"359_CR51","doi-asserted-by":"publisher","first-page":"6061","DOI":"10.7150\/THNO.42114","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang C, Xu Z, Di H, Zeng E, Jiang Y, Liu D (2020) Gadolinium-doped Au@prussian blue nanoparticles as MR\/SERS bimodal agents for dendritic cell activating and tracking. Theranostics 10:6061\u20136071. https:\/\/doi.org\/10.7150\/THNO.42114","journal-title":"Theranostics"},{"key":"359_CR52","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1158\/1078-0432.CCR-20-2770","volume":"27","author":"F Simonetta","year":"2021","unstructured":"Simonetta F, Alam IS, Lohmeyer JK et al (2021) Molecular imaging of chimeric antigen receptor T cells by ICOS-ImmunoPET. Clin Cancer Res 27:1058\u20131068. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-2770","journal-title":"Clin Cancer Res"},{"key":"359_CR53","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.2147\/CMAR.S238174","volume":"12","author":"C Liu","year":"2020","unstructured":"Liu C, Zhang Z, Ping Y et al (2020) Comprehensive analysis of PD-1 gene expression, immune characteristics and prognostic significance in 1396 glioma patients. Cancer Manag Res 12:4399\u20134410. https:\/\/doi.org\/10.2147\/CMAR.S238174","journal-title":"Cancer Manag Res"},{"key":"359_CR54","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1172\/JCI33583","volume":"118","author":"C Liu","year":"2008","unstructured":"Liu C, Lou Y, Liz\u00e9e G et al (2008) Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. J Clin Invest 118:1165\u20131175. https:\/\/doi.org\/10.1172\/JCI33583","journal-title":"J Clin Invest"},{"key":"359_CR55","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/J.DIII.2020.02.004","volume":"101","author":"C Fink","year":"2020","unstructured":"Fink C, Smith M, Sehl OC et al (2020) Quantification and characterization of granulocyte macrophage colony-stimulating factor activated human peripheral blood mononuclear cells by fluorine-19 cellular MRI in an immunocompromised mouse model. Diagn Interv Imaging 101:577\u2013588. https:\/\/doi.org\/10.1016\/J.DIII.2020.02.004","journal-title":"Diagn Interv Imaging"},{"key":"359_CR56","doi-asserted-by":"publisher","unstructured":"Boberg M, Gdaniec N, Szwargulski P, Werner F, M\u00f6ddel M, Knopp T (2021) Simultaneous imaging of widely differing particle concentrations in MPI: problem statement and algorithmic proposal for improvement. Phys Med Biol 66. https:\/\/doi.org\/10.1088\/1361-6560\/ABF202","DOI":"10.1088\/1361-6560\/ABF202"},{"key":"359_CR57","doi-asserted-by":"publisher","first-page":"e0164557","DOI":"10.1371\/JOURNAL.PONE.0164557","volume":"11","author":"C Gonzales","year":"2016","unstructured":"Gonzales C, Yoshihara HAI, Dilek N et al (2016) In-vivo detection and tracking of T cells in various organs in a melanoma tumor model by 19F-Fluorine MRS\/MRI. PLoS One 11:e0164557. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0164557","journal-title":"PLoS One"},{"key":"359_CR58","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1021\/ACS.NANOLETT.7B03829","volume":"18","author":"G Song","year":"2018","unstructured":"Song G, Chen M, Zhang Y et al (2018) Janus iron oxides @ semiconducting polymer nanoparticle tracer for cell tracking by magnetic particle imaging. Nano Lett 18:182\u2013189. https:\/\/doi.org\/10.1021\/ACS.NANOLETT.7B03829","journal-title":"Nano Lett"},{"key":"359_CR59","doi-asserted-by":"publisher","first-page":"988667","DOI":"10.3389\/FIMMU.2022.988667","volume":"13","author":"F Cooke","year":"2022","unstructured":"Cooke F, Neal M, Wood MJ et al (2022) Fluorine labelling of therapeutic human tolerogenic dendritic cells for 19F-magnetic resonance imaging. Front Immunol 13:988667. https:\/\/doi.org\/10.3389\/FIMMU.2022.988667","journal-title":"Front Immunol"},{"key":"359_CR60","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1038\/S41423-021-00728-2","volume":"18","author":"A P\u00e9rez-G\u00f3mez","year":"2021","unstructured":"P\u00e9rez-G\u00f3mez A, Vitall\u00e9 J, Gasca-Capote C et al (2021) Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection. Cell Mol Immunol 18:2128\u20132139. https:\/\/doi.org\/10.1038\/S41423-021-00728-2","journal-title":"Cell Mol Immunol"}],"container-title":["European Radiology Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-023-00359-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41747-023-00359-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-023-00359-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T20:03:00Z","timestamp":1692043380000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurradiolexp.springeropen.com\/articles\/10.1186\/s41747-023-00359-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1186\/s41747-023-00359-4","relation":{},"ISSN":["2509-9280"],"issn-type":[{"value":"2509-9280","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]},"assertion":[{"value":"7 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were performed in accordance with institutional and national guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}